Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21)
קרן | National Cancer Institute/NIH |
---|---|
מדינה | U.S.A. |
סוג | Research Grants |
תאריך אחרון | 29/09/2021 |
פקולטה | Exact Sciences, Life Sciences, Medicine |
תיאור | This grant will support the development of tools, devices, instrumentation, and associated methods to preserve or protect sample integrity, or establish verification criteria for quality assessment/quality control and handling under diverse conditions. These technologies are expected to accelerate and/or enhance research in cancer biology, early detection, and screening, clinical diagnosis, treatment, epidemiology, or address issues associated with cancer health disparities, by reducing pre-analytical variations that affect biospecimen sample quality.
Funding: $400,000 total Duration: 3 years
Research Autority due date: 10 days prior to submission LOI (encouraged) due dates: 22.1.21, 27.4.21, 29.8.21 Full proposal due dates: 22.2.21, 27.5.21, 29.9.21
|
קבצים מצורפים | |
קישור | לאתר |
עדכון אחרון | עדכון אחרון: 22/11/2020 |